Panimdim, Roma S.

HRN: 24-87-02  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/16/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
04/16/2026
04/23/2026
IV
500mg
Q8
Nonhealing Wound
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: